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(Received for publication July 25, 1987)
Wehave developed a method for gene replacement in Streptomyces hygroscopicus which
permits introduction of an in vitro derived mutation carried on a plasmid into the chromosome.
Weconstructed the plasmid pMSB212which can replicate in S. hygroscopicus and contains
the step5 gene of the bialaphos biosynthetic pathway which was inactivated by a frame-shift
mutation caused by filling in the cohesive ends of the EcoK I site in the structural gene.
pMSB212was introduced into a bialaphos producer strain and by protoplast regeneration of
the primary thiostrepton-resistant transformants, non-producing mutants, were obtained.
Biochemical and genetical analyses indicated that these mutants were specifically blocked by
introduction of the frame-shift mutation in the step5 gene on the chromosome.This method
will enable us to obtain isogenic mutants of knowngenes and to identify new genes encoded
on a cloned fragment.
Streptomycetes are very important microorganisms whichproduce manyantibiotics and enzymes
of commercial value. Recent developments in Streptomyces gene cloning have resulted in cloning
of the resistance, biosynthetic, and regulatory genes of antibiotics, and elucidation of Streptomyces
gene organization and regulation1~7).
Mutant analysis gives us much information about gene function and regulation. Mutants usually
have been obtained by using chemical or physical mutagens, but there have been reports recently about
another mutagenic approach, gene replacement techniques in Escherichia coli8), Bacillus subtilis9~12:>
or Saccharomyces cerevisiae13 > 14\
It is desirable to devise a method for generating specific mutations in the chromosomesof strepto-
mycetes. Chater and Bruton have developed the mutational cloning method using derivatives of
temperate phage and applied it to Streptomyces coelicolor and Streptomyces Hvidansl)'.
In this paper we describe a method that allows the introduction of an in vitro derived mutation
carried on the plasmid into the chromosome of Streptomyces hygroscopicus. This approach is based
on our finding that recombination between the host chromosome and a plasmid containing a homo-
logous region to it occurred in S. hygroscopicus6>7\ which produces a tripeptide antibiotic, bialaphos15).
Materials and Methods
Bacterial Strains and Plasmids
S. lividans 66 was kindly supplied by Dr. N. D. Lomovskaya and Dr. K. F. Chater. S. hy-
groscopicus strains are listed in Table 1. Plasmid pMSB726) has a 670 bp Sph I-Bgl II fragment con-
taining a portion of the step5 gene in pIJ702.
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DNAManipulation and Transformation
Chromosomal DNAwas isolated as de-
scribed by Smith in Hopwoodet al.w. Plasmid
preparations from streptomycetes were carried
out as described by Murakami et al.w. Restric-
tion enzymes and T4 DNA-Ligase(Takara Shuzo
Co., Ltd., or Toyobo Co., Ltd.), and calf intestinal
alkaline phosphatase were used according to the
recommendations of the suppliers. DNApoly-
merase I (Klenow fragment, Takara Shuzo Co.,
Ltd.) was used to fill in the site of EcoRI ac-
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Table 1. Strains of Streptomyces hygroscopicus.

















cording to the protocol of Maniatis et al.18\ Gel electrophoresis of DNAwas done according to
Hopwoodet al.16\ Transformation of $. Hvidans protoplasts was carried out by the method of
Thompson et «/.19). S. hygroscopicus was transformed according to Murakami et aL6).
Protoplast Regeneration and Curing of Plasmids
Protoplast regeneration of S. hygroscopicus was carried out in the same manneras its transforma-
tion, but in the absence of thiostrepton. Thiostrepton-sensitive clones were scored on Nutrient agar
(Difco) containing 20 ^g/ml of thiostrepton.
Bialaphos Productivity and Co-synthesis Tests
The production of bialaphos was detected by a conventional agar plug assay. Agar plugs of A4
medium20) were inoculated and incubated for 5 days at 28°C. The plugs were then placed on the
surface of the bialaphos assay agar mediumof Ogawaet aL20) seeded with lawns of the bialaphos-
sensitive indicator bacterium, Bacillus subtilis ATCC6633. For the co-synthesis tests, mycelial sus-
pensions of two non-producing mutants were spread about 2 mmapart on opposite halves of a Petri
dish containing A4 medium. After 5 days of growth at 28°C, an agar strip was removed from the
center of the plate and placed on a bialaphos assay plate.
Preparation of Cell Extracts
Cultures of S. hygroscopicus were grown at 28°C for 4 days in 30 ml of liquid production medium70.
Mycelium was collected by centrifugation and then washed twice in cold TMbuffer (50 mMTris-HCl,
5 /MM2-mercaptoethanol, pH 7.0). Washed mycelium was suspended in 20 ml of TMbuffer and
disrupted by sonication. Cell debris was removed by centrifugation (17,000 x g9 20 minutes, 4°C).
SDS-polyacrylamide Gel Electrophoresis (PAGE)
SDS-PAGEwas carried out according to Laemmli21). Samples were denatured at 100°C for 5
minutes in the presence of 1 % SDS and 10% 2-mercaptoethanol before loading on a 12.5%-poly-
acrylamide gel. Weused the SDS-PAGEStandard [Low] (Bio-Rad) as protein size markers.
Southern Hybridization
Transfer of DNAfrom agarose gels to nylon membranes (Hybond-N, Amersham, Ltd.) were
carried out by the method of Southern223 following the recommendation of the suppliers. DNA
probes were labeled by the Nick Translation Kit (Amersham, Ltd.). Pre-hybridization and hybridiza-
tion were done as described in Hopwoodet #/.16).
Results
Construction of Plasmids Carrying the Inactivated Step5 Gene
pMSB27(Fig. 1) contains the entire step5 gene of the bialaphos biosynthetic pathway, and has
a unique EcoRl site located within this gene. pMSB27DNAwas digested with EcoRI and the
cohesive ends were filled in by treating it with DNApolymerase I (Klenow fragment). The ligated
plasmid DNAwas digested with EcoR I again and used to transform S. lividans. Thiostrepton-
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Fig. 1. Construction of plasmids carrying the inactivated step5 gene.
Above mapindicates the bialaphos biosynthetic gene cluster. Numbers under the maprepresent
steps of the biosynthetic pathway.
bar: Bialaphos-resistant gene, brpA: bialaphos regulatory gene. pM8B27 was constructed by the
insertion of a 3.0-kb BamHI fragment into the BamHI site of pIJ680. Thick lines, Streptomyces hygros-
copicus sequences ; thin lines, vector sequences.
Table 2. Isolation of non-producing mutants from HP5-29 containig pMSB212and pMSB27.
Producer Non-producer
Total
Thio r Thio s Thior Thio s
pMSB212 1 81 14 4 1 200
pMSB27 1 53 47 0 0 200
Thio : Thiostrepton, r : resistant, s : sensitive.
resistant transformants were selected. Most of the transformants contained the same plasmid,
pMSB212, lacking the EcoK I site (Fig. 1). The digestion pattern of pMSB212with other restriction
endonucleases was the same as pMSB27.
Isolation of Mutants Blocked at Step5
pMSB212and pMSB27were introduced into S. hygroscopicus HP5-29 and thiostrepton-resistant
clones were selected. Protoplasts prepared from these clones were spread on regeneration plates
without thiostrepton. Two hundred colonies from each regenerated clone were picked onto Nutrient
agar without thiostrepton and replicated to Nutrient agar containing thiostrepton, and to agar plugs
containing A4 mediumto measure thiostrepton sensitivity and bialaphos productivity. Five bialaphos
non-producing mutants from HP5-29 containing pMSB212were obtained but none from the trans-
formants containing pMSB27(Table 2). Four out of 5 non-producing mutants still contained the
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Table 3. Co-synthesis test of the generated mutants.
Mntsi n t NP47 NP46 NP22 1 NP2 1 3 NP44 NP45 NP8
MUtant (l) a (3) (4) (5) (6) (12) (1 3)
VM1 + + + - + + +
VM2-1 + + + - + + +
VM2-2 + + + - + + +
VM2-3 + +å + - 'à" + ' + +
VM2-4 + + + - + +' +
NP21 3 + + + + + +
a Number in parenthesis shows blocked step.
+, - : Bialaphos production.
plasmid, pMSB212. We designated the thio-
strepton-sensitive non-producer as VM1and the
thiostrepton-resistant ones as VM2-1, 2-2, 2-3
and 2-4.
Co-synthesis Test of the Generated Mutants
To determine which step was defective in
VM1, 2-1, 2-2, 2-3, and 2-4, a co-synthesis test was
done. All mutants could convert intermediates
secreted by NP44, NP45, and NP8, which are
blocked at step6, 12 and 13, respectively (Table
3). Futhermore, these mutants secreted inter-
mediates which NP47, NP46 and NP221 could
convert to bialaphos. However, NP213, which
is blocked at step5, was not able to produce
bialaphos in a co-synthesis test with these mu-
tants.
Analysis of Intracellular Protein
SDS-PAGEanalysis of intracellular proteins
showed that a 32K-dalton protein, which is the
product of the step5 gene, could not be detected
in mutant VM1.The amounts of other proteins
Fig. 2. SDS-PAGEprofiles of VM1 and its parent
HP5-29 during production phase. (1) HP5-29,
(2) VM1.
Numbers at the left of the figure are the MWof
size markers.
were the same as those of the parent strain HP5-29 (Fig. 2). Demethylphosphinothricin (DMPT) acetyl-
;ransferase activity, which is the product of steplO, was about the same in strains VM1and HP5-29
;0.155 and 0.170 u/mg protein, respectively).
Southern Hybridization
Southern analysis was used to confirm the genotype of VM1.ChromosomalDNAs,obtained
from VM1and its parent HP5-29, was digested with BamUI, EcoR I and both BamHI and EcoRI,
then electrophoresed on agarose gels, and transferred to nylon membranes. The hybridization pat-
tern of these DNAs, when probed with 32P-labeled pMSB27, is shown in Fig. 3. The hybridization
data in lane 4 compared with lane 3 confirm the restriction pattern expected for replacement of the
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Table 4. Recovery of bialaphos productivity in
VM1.
c+*. ;« Relative






normal DNAfragment containing the step5 gene
with one lacking the internal EcoR I site (Fig. 1).
There are two bands, 0.7 kb and 2.3 kb in size,
in lane 3 but only one band, 3.0kb in size, in
lane 4. This observation suggests the lack of the
EcoRI site in the step5 gene locus within the 3.0-
kb BamHI fragment on the VM1chromosome.
Restoration of Bialaphos Production
by Re-transformation
VM1has already been cured of the plasmid
pMSB212. Therefore we re-transformed VM1
with pMSB27,pMSB212and pMSB72which contained the wild-type, mutant-type and a portion of
step5 gene, respectively. As shown in Table 4, pMSB27and pMSB72could restore the bialaphos
productivity in VM1but pMSB212 could not. VM1containing pMSB72produced a low level of
bialaphos compared with the parent strain HP5-29, because this restoration might be caused by re-
combination between the plasmid and the chromosome6).
Discussion
In this report, we have described a method for replacing a specific chromosomal locus in S. hy-
groscopicus with altered DNAsequences constructed in vitro. Other examples of gene replacement
in the Streptomyces have been reported: i) Recombination between the mutant chromosome and the
homologous region of cloned act gene cluster in S. coelicolor2), ii) the gene homogenetization of bald
genes in S. coelicolor2B).
Weassume that the replacement of the genomic segments with altered DNAsequences on the
plasmid depended on in vivo homologous recombination. Thus the location of the base substitution
mutation and the size of a deletion or an insertion within the cloned fragment should be important.
Since it is presumed that the frequency of homologous recombination between a plasmid and chro-
mosomeincreases with the size of homologous regions on both sides of a mutation, large insertions
or deletions will decrease the efficiency of gene replacements.
In the case of the step5 gene, we could not obtain non-producing mutants directly by the trans-
formation of a bialaphos producer strain with pMSB212.By protoplast regeneration of a producer
strain containing pMSB212,we were able to isolate the desired mutants, and to cure the strain of the
resident plasmid at a frequency of ca. 7 %. However, if the mutant obtained still possesses a plasmid,
it is possible to cure it by repeated protoplast regeneration (Y. Kumadaet aL, and O. Hara et aL; in
preparation). Therefore the protoplast regeneration procedure was indispensable to both single
colony isolation of mutants and plasmid curing.
Co-synthesis tests showed that the non-producing mutants, YM1and others, isolated by our gene
Fig. 3. Southern hybridization of 32P-labeled
pMSB27 DNA to HP5-29 (lanes 1, 3 and 5) and
VM1(lanes 2, 4 and 6) chromosomal DNAs digested
with BamRI (lanes 1 and 2), EcoK I (lanes 5 and 6)
and both BamHI and EcoR I (lanes 3 and 4).
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Fig. 4. Putative pathways of gene replacement in Streptomyces hygroscopicus.
replacement method and NP213, obtained by the conventional mutation method, are blocked at step5
of the bialaphos biosynthetic pathway and are isogenic. Moreover VM1accumulated phosphinoformic
acid and could convert phosphinomethylmalic acid to bialaphos like NP213 (data not shown).
We have already reported that the product of the step5 gene is a 32K-dalton protein and is pro-
duced in a large amount by a producer strain70. SDS-PAGEanalysis indicated the loss of a 32K-
dalton protein mutant in VM1, as in NP2137), and the restoration of its lesion by introduction of plasmid
pMSB27containing all of the step5 gene. Therefore, VM1is a step5 blocked mutant like NP213.
Southern hybridization analysis showed that VM1lacks the EcoKI site in the step5 structual
gene on the chromosome. Moreover pMSB212could not restore the bialaphos productivity of VM1,
although both pMSB27and pMSB72containing an entire or a portion of this gene, respectively, could
do so. These observations indicate that the mutation on the chromosomeof VM1is located at an
EcoKI site as expected.
The pathway for replacement of a chromosomal segment with an altered sequence in E. coli, B.
subtilis and $. cerevisiae has been elucidated9~14). Since we used a replicating vector in S. hygro-
scopicus, pIJ680, instead of a suicide vector, it is thought that the mechanism of replacement in this
strain differed from that of E. coli8} and S. cerevisiaelz>u:>.
Weassume that there are two possibilities for the mechanismof the gene replacement in S. hy-
groscopicus as shown in Fig. 4. One is by a double crossover and another is by a single crossover
leading to integration and a subsequent excision. Because both systems result in the same product,
we must perform further experiments to determine which mechanism is operating in S. hygroscopicus.
This gene replacement method should be applied to other Streptomyces species and would be
useful for the following purposes: i) The isolation of an isogenic mutant of a known gene already
defined; for example, a blocked mutant of an antibiotic or an auxotroph mutant, ii) the improvement
of a host-vector system by the inactivation of unfavorable genes; for example, protease or restriction
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enzyme genes, iii) the identification of an unknown gene located on the cloned DNAfragment
by the loss of an identifiable function. Weemphasize the possible application to the last purpose.
Gene cloning experiments have revealed that the genes which code for the resistance to and biosyn-
thesis of antibiotics are closely linked1»4>6>24), and moreover that regulatory genes can be located in the
gene cluster1»4»7). Thusthis newtechnique should enable one to elucidate whether unknownbiosyn-
thetic or regulatory genes of antibiotics are located close to the production or resistance genes which
have already been cloned. For example, some new genes of the bialaphos biosynthetic pathway
encoded on a cloned DNAfragment have been identified recently using this method (Y. Kumada
et al.9 and O. Hara et al.\ in preparation).
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